Literature DB >> 22209795

Actions of translocator protein ligands on neutrophil adhesion and motility induced by G-protein coupled receptor signaling.

Camila Bento de Lima1, Eduardo K Tamura, Trindad Montero-Melendez, João Palermo-Neto, Mauro Perretti, Regina P Markus, Sandra Helena Poliselli Farsky.   

Abstract

The 18 kDa translocator protein (TSPO) also known as the peripheral benzodiazepine receptor (PBR), mediates the transportation of cholesterol and anions from the outer to the inner mitochondrial membrane in different cells types. Although recent evidences indicate a potential role for TSPO in the development of inflammatory processes, the mechanisms involved have not been elucidated. The present study investigated the ability of the specific TSPO ligands, the isoquinoline carboxamide PK11195 and benzodiazepine Ro5-4864, on neutrophil recruitment promoted by the N-formylmethionyl-leucyl-phenylalanine peptide (fMLP), an agonist of G-protein coupled receptor (GPCR). Pre-treatment with Ro5-4864 abrograted fMLP-induced leukocyte-endothelial interactions in mesenteric postcapillary venules in vivo. Moreover, in vitro Ro5-4864 treatment prevented fMLP-induced: (i) L-selectin shedding and overexpression of PECAM-1 on the neutrophil cell surface; (ii) neutrophil chemotaxis and (iii) enhancement of intracellular calcium cations (iCa(+2)). Intriguingly, the two latter effects were augmented by cell treatment with PK11195. An allosteric agonist/antagonist relation may be suggested, as the effects of Ro5-4864 on fMLP-stimulated neutrophils were reverted by simultaneous treatment with PK11195. Taken together, these data highlight TSPO as a modulator of pathways of neutrophil adhesion and locomotion induced by GPCR, connecting TSPO actions and the onset of an innate inflammatory response.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209795     DOI: 10.1016/j.bbrc.2011.12.078

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Early-stage 11C-Flumazenil PET predicts day-14 selective neuronal loss in a rodent model of transient focal cerebral ischemia.

Authors:  Jessica L Hughes; John S Beech; P Simon Jones; Dechao Wang; David K Menon; Franklin I Aigbirhio; Tim D Fryer; Jean-Claude Baron
Journal:  J Cereb Blood Flow Metab       Date:  2019-10-22       Impact factor: 6.200

2.  A Case of Stiff Person Syndrome: Immunomodulatory Effect of Benzodiazepines: Successful Rituximab and Tizanidine Therapy.

Authors:  Przemyslaw Zdziarski
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

3.  Role of Translocator 18 KDa Ligands in the Activation of Leukotriene B4 Activated G-Protein Coupled Receptor and Toll Like Receptor-4 Pathways in Neutrophils.

Authors:  Léonard de Vinci Kanda Kupa; Carine C Drewes; Eric D Barioni; Camila L Neves; Sandra Coccuzzo Sampaio; Sandra H P Farsky
Journal:  Front Pharmacol       Date:  2017-10-27       Impact factor: 5.810

4.  Achyrocline satureioides (Lam.) D.C. Hydroalcoholic Extract Inhibits Neutrophil Functions Related to Innate Host Defense.

Authors:  Eric Diego Barioni; José Roberto Santin; Isabel Daufenback Machado; Stephen Fernandes de Paula Rodrigues; Viviane Ferraz-de-Paula; Theodoro Marcel Wagner; Bruno Cogliati; Matheus Corrêa Dos Santos; Marina da Silva Machado; Sérgio Faloni de Andrade; Rivaldo Niero; Sandra Helena Poliselli Farsky
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-11       Impact factor: 2.629

5.  The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions.

Authors:  Omid Sascha Yousefi; Thomas Wilhelm; Karin Maschke-Neuß; Marcel Kuhny; Christian Martin; Gerhard J Molderings; Felix Kratz; Bernd Hildenbrand; Michael Huber
Journal:  Cell Commun Signal       Date:  2013-02-20       Impact factor: 5.712

6.  Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool.

Authors:  Mayara Klimuk Uchiyama; Sergio Hiroshi Toma; Stephen Fernandes de Paula Rodrigues; Ana Lucia Borges Shimada; Rodrigo Azevedo Loiola; Hernán Joel Cervantes Rodríguez; Pedro Vitoriano Oliveira; Maciel Santos Luz; Said Rahnamaye Rabbani; Henrique Eisi Toma; Sandra Helena Poliselli Farsky; Koiti Araki
Journal:  Int J Nanomedicine       Date:  2015-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.